Wednesday, December 24, 2008

FDA Approves Ferring Pharmaceuticals' Degarelix (Generic Name) for Treatment of Advanced Prostate Cancer

|More|
Thursday, December 18, 2008

Committee for Medicinal Products for Human Use (CHMP) recommends granting marketing authorisation for FIRMAGON® (degarelix) for treatment of prostate cancer New gonadtropin-releasing hormone (GnRH) receptor antagonist demonstrates rapid, long-term suppression of testosterone

|More|
Wednesday, December 10, 2008

Ferring and Conaris complete license agreement for new recombinant molecule in gastroenterology

|More|
Wednesday, December 03, 2008

Ferring signs distribution agreement with BioGaia in Ireland and the Middle East.

|More|
Monday, December 01, 2008

Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim® in Europe with Ferring Pharmaceuticals

|More|
Thursday, March 27, 2008

Positive phase III data unveiled for new GnRH blocker degarelix

|More|
Thursday, February 28, 2008

Ferring Pharmaceuticals submits new drug application for degarelix, a prostate cancer treatment

|More|
Wednesday, January 30, 2008

Launch of new, prestigious infertility and gynaecology research grant (FRIGGA) at "Update in Infertility 2008"

|More|
 

By using the service, you agree to the following:

Your email address and the recipient's email address will be used for transmission purposes only - to inform the addressee about the sender, or for sending a message in the event of a transmission error. Both email addresses will be deleted from our system after a short period.